戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 arrow rescue in relapsed medulloblastoma and germinoma.
2 sy in the pediatric population for suspected germinoma.
3 re seen in patients with medulloblastoma and germinomas.
4  Seventy-one patients were enrolled (45 with germinoma and 26 with nongerminomatous GCT [NGGCT]).
5 of efficacy in the treatment of intracranial germinoma and it remains the standard therapy with which
6 es from 12 patients with CNS-GCT patients (8 germinomas and 4 NGGCTs).
7                      The CR rate was 84% for germinomas and 78% for NGGCT.
8 otherapy is the best treatment for localised germinomas and conclude that reduced-volume radiotherapy
9 tive therapy for patients with recurrent CNS germinomas and might be effective in patients with recur
10 nt differences in abundance in patients with germinomas and NGGCTs.
11                    Four patients (three with germinomas and one with mixed GCT) presented with leptom
12 lastoma, Oligodendroglioma, Medulloblastoma, Germinoma, and Schwannoma.
13 germinomatous germ cell tumors (NGGCTs) from germinomas are critical, as these have a distinct progno
14 urgery in GCTs and the optimal treatment for germinomas as well as mixed malignant GCTs.
15                                              Germinoma diagnosis was rendered in 7 of 9 patients; 1 p
16                            Nine patients had germinomas; eight had mixed GCT.
17                                Patients with germinoma fared better than those with NGGCTs (P =.016 a
18  CNS-GCTs and can be useful to differentiate germinomas from NGGCTs.
19 ted pituitary stalk thickening for suspected germinoma is generally safe with high diagnostic utility
20 osarcoma (n = 1), neuroblastoma (n = 1), and germinoma (n = 1), for an overall response rate of 5%.
21 umor (n = 6), ependymoma (n = 3), and pineal germinoma (n = 1).
22               The remaining 184 patients had germinoma (n = 20), malignant teratoma (n = 55), embryon
23 ), astrocytoma (n = 10), ependymoma (n = 5), germinoma (n = 3), atypical teratoid rhabdoid tumor (n =
24                 Importantly, 22% of presumed germinomas on imaging yielded alternative diagnoses on b
25 probability of surviving 2 years was .84 for germinoma patients and .62 for NGGCT.
26 optimum management of localised intracranial germinoma remains controversial.
27 n, testes, or ovaries, where they are termed germinomas, seminomas, or dysgerminomas, respectively.
28            Seven of nine (78%) patients with germinoma survived disease-free after HDC with a median
29 medulloblastoma (CR and three PRs), two with germinomas (two CRs), and one with ependymoma (one CR).